J&J delays vaccine rollout in Europe amid clot fears in US

Johnson & Johnson said Tuesday it is delaying the rollout of its coronavirus vaccine in Europe amid a U.S. probe into reports of rare blood clots in some recipients, moves that experts worry could further shake vaccine confidence and complicate COVID-19 immunization efforts. The announcement came after regulators in the United States said they were recommending a "pause" in